Decentralized Trials: The Value of Direct-to-Patient & Pharmacy-Led Solutions
Abstract: Decentralized clinical trials (DCTs) are reshaping the clinical research landscape by improving access, compliance, and operational efficiency. This article reveals how pharmacy-led direct-to-patient (DTP) models serve as the backbone of scalable, modern trial supply chains, offering seamless delivery, regulatory assurance, and real patient-centricity.
By shifting the investigational product distribution away from traditional clinical sites and toward a pharmacy-driven approach, sponsors can streamline logistics, reduce trial site burden, and enhance diversity and patient retention. Learn how strategic partnerships with licensed pharmacies drive the success of DCTs and align with FDA guidance on decentralized elements in clinical trials.
Download this article to explore actionable strategies, regulatory considerations, and best practices for adopting pharmacy-led DTP models in your next clinical study.